A 32‐bp deletion (2991del32) in the cystic fibrosis gene associated with CFTR mRNA reduction

Cystic fibrosis, a common recessive disorder of exocrine glands, is caused by mutations in the cystic fibrosis transmembrane conductance regulator (CFTR) gene. We describe the identification of a 32‐bp deletion within the coding region of CFTR that involves the nucleotides 2991–3022 in exon 15 (2991del32). This unusual frameshift mutation was confirmed in three unrelated German families, accounting for a frequency of 0.3% in 1,028 CF chromosomes. AH identified patients are compound heterozygotes for 2991del32 and for the most frequent cystic fibrosis mutation, ΔF508. The evaluation of clinical data revealed typical symptoms of cystic fibrosis, including pancreatic insufficiency, in all three index cases. To characterize further the mutation in the CFTR transcript, we analysed RNA from lymphocytes by reverse transcription and PCR amplification. 2991del32 transcripts were detectable neither in the RNA sample from a patient compound heterozygous ΔF508/2991del32 nor in the parental sample heterozygous wild‐type/2991del32. These data indicate that the 32‐bp deletion causes a pancreas insufficient cystic fibrosis phenotype by a severe reduction of CFTR mRNA. © 1994 Wiley‐Liss, Inc.

[1]  J. Gustafson,et al.  Cystic Fibrosis , 2009, Journal of the Iowa Medical Society.

[2]  T. Dörk,et al.  A donor splice mutation (405 + 1 G-->A) in cystic fibrosis associated with exon skipping in epithelial CFTR mRNA. , 1993, Human molecular genetics.

[3]  K. Will,et al.  CFTR transcripts are undetectable in lymphocytes and respiratory epithelial cells of a CF patient homozygous for the nonsense mutation R553X. , 1993, Journal of medical genetics.

[4]  M. Welsh,et al.  Molecular mechanisms of CFTR chloride channel dysfunction in cystic fibrosis , 1993, Cell.

[5]  L. Tsui,et al.  Analysis of CFTR transcripts in nasal epithelial cells and lymphoblasts of a cystic fibrosis patient with 621 + 1G-->T and 711 + 1G-->T mutations. , 1993, Human molecular genetics.

[6]  A. Harris,et al.  Abnormal mRNA splicing resulting from three different mutations in the CFTR gene. , 1993, Human molecular genetics.

[7]  A. Hamosh,et al.  CFTR nonsense mutations G542X and W1282X associated with severe reduction of CFTR mRNA in nasal epithelial cells. , 1992, Human molecular genetics.

[8]  M. Corey,et al.  Genetic determination of exocrine pancreatic function in cystic fibrosis. , 1992, American journal of human genetics.

[9]  F. Collins,et al.  Cystic fibrosis: molecular biology and therapeutic implications. , 1992, Science.

[10]  M. White,et al.  A 22-bp deletion in the coding region of the cystic fibrosis gene. , 1992, Genomics.

[11]  A. Ferguson,et al.  Three novel mutations in the cystic fibrosis gene detected by chemical cleavage: analysis of variant splicing and a nonsense mutation. , 1992, Human molecular genetics.

[12]  J. Riordan,et al.  Purification and functional reconstitution of the cystic fibrosis transmembrane conductance regulator (CFTR) , 1992, Cell.

[13]  T. McDonald,et al.  Human lymphocytes transcribe the cystic fibrosis transmembrane conductance regulator gene and exhibit CF-defective cAMP-regulated chloride current. , 1992, The Journal of biological chemistry.

[14]  A. Hamosh,et al.  Severe deficiency of cystic fibrosis transmembrane conductance regulator messenger RNA carrying nonsense mutations R553X and W1316X in respiratory epithelial cells of patients with cystic fibrosis. , 1991, The Journal of clinical investigation.

[15]  A. Harris,et al.  Lymphocyte mRNA as a resource for detection of mutations and polymorphisms in the CF gene. , 1991, Journal of medical genetics.

[16]  L. Tsui,et al.  Genomic DNA sequence of the cystic fibrosis transmembrane conductance regulator (CFTR) gene. , 1991, Genomics.

[17]  M. Welsh,et al.  Generation of cAMP-activated chloride currents by expression of CFTR. , 1991, Science.

[18]  L. Tsui,et al.  Erratum: Identification of the Cystic Fibrosis Gene: Cloning and Characterization of Complementary DNA , 1989, Science.

[19]  L. Tsui,et al.  Erratum: Identification of the Cystic Fibrosis Gene: Genetic Analysis , 1989, Science.

[20]  J. Riordan,et al.  Identification of the Cystic Fibrosis Gene : Chromosome Walking and Jumping Author ( s ) : , 2008 .

[21]  M. Beato.  Gene regulation by steroid hormones , 1989, Cell.

[22]  P. Chomczyński,et al.  Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. , 1987, Analytical biochemistry.

[23]  Taylor,et al.  Model for the participation of quasi-palindromic DNA sequences in frameshift mutation. , 1982, Proceedings of the National Academy of Sciences of the United States of America.

[24]  P Chambon,et al.  Isolation of high-molecular-weight DNA from mammalian cells. , 1973, European journal of biochemistry.

[25]  F. Collins,et al.  An African‐American cystic fibrosis patient homozygous for a novel frameshift mutation associated with reduced CFTR mRNA levels , 1993, Human mutation.

[26]  B. Dallapiccola,et al.  Molecular characterization of a frameshift mutation in exon 19 of the CFTR gene , 1993, Human mutation.

[27]  L. Tsui,et al.  A suggested nomenclature for designating mutations , 1993, Human mutation.

[28]  L. Tsui,et al.  Mutations and sequence variations detected in the cystic fibrosis transmembrane conductance regulator (CFTR) gene: A report from the cystic fibrosis genetic analysis consortium , 1992, Human mutation.

[29]  M. Iannuzzi,et al.  Characterization of an intron 12 splice donor mutation in the cystic fibrosis transmembrane conductance regulator (CFTR) gene , 1992, Human mutation.

[30]  Charles R.scriver.  The Metabolic basis of inherited disease , 1989 .

[31]  L. Tsui,et al.  Identification of the cystic fibrosis gene: cloning and characterization of complementary DNA. , 1989, Science.

[32]  L. Tsui,et al.  Identification of the cystic fibrosis gene: genetic analysis. , 1989, Science.